The increasing awareness about chronic diseases has rendered patients and their families more informed than ever. As a result of this an increasing number of people around the world often get blood samples tested for any sign of health disorder or diseases. The need for blood tests for checking red blood count, white blood count, and detect any disease is boosting the global hematology analyzers and reagents market predicts Fortune Business Insights in their new study. The report is titled, “Hematology Analyzers and Reagents Market Size, Share and Global Trend By Product Type (Instruments, Reagents), By End User (Diagnostic Laboratories, Hospitals & Clinics, Research institutes, Others), and Geography Forecast till 2026”.
Dynamic Presence of Major Market Players Helping North America Emerge Dominant
Geographically, Fortune Business Insights projects the global hematology analyzers and reagents market to be dominated by North America, followed by Europe. This is on account of the dynamic presence of major market players in the region. These market vendors are investing huge sums for research and development of devices that generate accurate results.
On the other side, the increasing awareness about hematological disorders and rise in the number of diagnostic clinics worldwide are helping the market in Europe gain momentum. The increasing prevalence of hematological disorders in Latin America and the Middle East and Africa, and Asia Pacific is prognosticated to help the market gain traction in the aforementioned regions.
Get PDF Brochure of this Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hematology-analyzers-and-reagents-market-101028.
By Product Type
- Semi-automated analyzers
- Fully automated analyzers
- Point-of-care testing
By End User
- Diagnostic laboratories
- Hospitals & Clinics
- Research institutes
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Key players leading the global surgical robots market include
- ERBA Diagnostics,
- Ortho Clinical Diagnostics Hoffmann-La Roche Ltd(Switzerland),
- Nihon Kohden (Japan),
- Sysmex Corporation (Japan),
- Boule Diagnostics (Sweden),
- BioSystems (Spain),
- Drew Scientific (US),
- Siemens (Germany),
- HORIBA (Japan),
- Diatron (Hungary),
- Beckman Coulter,
- Siemens AG,
- EKF Diagnostics (UK),
- Bio-Rad Laboratories (US),
- Mindray (China),
- Sysmex Danaher (US),
- Abbott Laboratories (US)
Some of the companies functioning in the global market are ERBA Diagnostics, Ortho Clinical Diagnostics Hoffmann-La Roche Ltd(Switzerland), Nihon Kohden (Japan), Sysmex Corporation (Japan), Boule Diagnostics (Sweden), BioSystems (Spain), Drew Scientific (US), Siemens (Germany), HORIBA (Japan), Diatron (Hungary), Beckman Coulter, Siemens AG, EKF Diagnostics (UK), Bio-Rad Laboratories (US), Mindray (China), Sysmex Danaher (US), Abbott Laboratories (US).
More Trending Topics From Fortune Business Insights: